Preliminary findings on COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH | COVID-19 Update
Preliminary findings on COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH | COVID-19 Update
AMA CXO Todd Unger reviews the latest on vaccines for children ages 6 months through 4 years, as well as boosters for 5-11 year olds with AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. Also covering CDC's recommendation on a second booster shot for people 50 or older, and the latest on the monkeypox outbreak.0:00 AMA COVID-19 Update for May 25, 2022
0:35 FDA authorized Pfizer COVID booster for children in the 5-11 age group last Tuesday
0:46 ACIP recommended a booster dose for all children aged 5 to 11; CDC endorsed the recommendation later that same day
1:53 AMA supports ACIP's recommendation for third dose COVID booster for children 5-11 years old
2:52 Booster recommendation was based on data Pfizer reported in April
4:12 Only one in three children between the ages of 5 and 11 in the U.S. have received two doses of the COVID vaccine
5:15 CDC now recommends all people 50 or older should get a second booster shot if at least four months have passed since their first COVID booster dose
6:23 Pfizer reported preliminary findings of a clinical trial for children under 5 years old
7:46 More than 45 percent of Americans now live in areas with high transmission rates and should consider wearing a mask in indoor public settings
8:56 Hospitalizations are now increasing in all but five U.S. states and territories
10:26 WHO panel concluded that governments around the world are no better prepared today to address a new global disease threat than they were just before the coronavirus outbreak
11:53 What is the latest on the monkeypox virus?
Stay up to date on the latest information about the pandemic: https://ama-assn.org/covid-19-resources.
Visit the COVID-19 Daily Video Updates page for more videos in this series: https://ama-assn.org/covid-19-videos.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.